心脏磁共振成像对非缺血性扩张型心肌病的风险分层:系统综述与Meta分析
该系统综述与Meta分析纳入103项研究、29687例非缺血性扩张型心肌病患者,评估心脏磁共振测量指标与临床结局的关联。结果显示晚期钆增强的存在和范围与全因死亡、心血管死亡、心律失常事件和心力衰竭事件风险升高相关,而左心室射血分数与死亡及心律失常终点无显著关联。作者认为native T1、细胞外容积分数和整体纵向应变的风险分层价值需进一步评估。
要点
- 晚期钆增强的存在与全因死亡风险升高相关(HR 1.81,95%CI 1.60-2.04)。
- 左心室射血分数每升高1%与心力衰竭事件风险降低相关(HR 0.97,95%CI 0.95-0.98)。
- 左心室射血分数与全因死亡、心血管死亡及心律失常事件无显著关联。
核心结论
- 晚期钆增强的存在和范围与多种不良临床结局相关,而左心室射血分数与死亡及心律失常终点无显著关联。
- 使用native T1弛豫时间、细胞外容积分数和整体纵向应变进行风险分层需进一步评估。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、Embase、Cochrane Library和Web of Science Core Collection数据库2005年1月至2023年4月的文献。
- 纳入报告心脏磁共振测量指标与非缺血性扩张型心肌病不良临床结局关联的前瞻性和回顾性非随机诊断性研究。
- 共分析103项研究、29687例非缺血性扩张型心肌病患者,由2名独立评价者提取数据,采用随机效应模型。
主要发现
- 晚期钆增强的存在与全因死亡风险升高相关(HR 1.81,95%CI 1.60-2.04;P<.001),晚期钆增强范围每增加1%与全因死亡风险升高相关(HR 1.07,95%CI 1.02-1.12;P=.02)。
- 晚期钆增强的存在与心血管死亡风险升高相关(HR 2.43,95%CI 2.13-2.78;P<.001),范围每增加1%与心血管死亡风险升高相关(HR 1.15,95%CI 1.07-1.24;P=.01)。
- 晚期钆增强的存在与心律失常事件风险升高相关(HR 2.69,95%CI 2.20-3.30;P<.001),范围每增加1%与心律失常事件风险升高相关(HR 1.07,95%CI 1.03-1.12;P=.004)。
- 晚期钆增强的存在与心力衰竭事件风险升高相关(HR 1.98,95%CI 1.73-2.27;P<.001),范围每增加1%与心力衰竭事件风险升高相关(HR 1.06,95%CI 1.01-1.10;P=.02)。
- 左心室射血分数每升高1%与全因死亡(HR 0.99,95%CI 0.97-1.02;P=.47)、心血管死亡(HR 0.97,95%CI 0.94-1.00;P=.05)和心律失常事件(HR 0.99,95%CI 0.97-1.01;P=.34)无显著关联。
关键数值与推荐
- 晚期钆增强的存在与全因死亡风险升高相关(HR 1.81,95%CI 1.60-2.04;P<.001)。
- 左心室射血分数每升高1%与心力衰竭事件风险降低相关(HR 0.97,95%CI 0.95-0.98;P=.002),与主要不良心血管事件风险降低相关(HR 0.98,95%CI 0.96-0.99;P<.001)。
- native T1弛豫时间每增加10 ms与心律失常事件风险升高相关(HR 1.07,95%CI 1.01-1.14;P=.04),与主要不良心血管事件风险升高相关(HR 1.06,95%CI 1.01-1.11;P=.03)。
- 整体纵向应变每升高1%与心力衰竭事件(HR 1.06,95%CI 0.95-1.18;P=.15)和主要不良心血管事件(HR 1.03,95%CI 0.94-1.14;P=.43)无显著关联。
- 关于native T1弛豫时间、整体纵向应变和细胞外容积分数与死亡结局的分析,数据有限,无法进行确定性分析。
临床怎么用
- 原文未据此给出推荐。
局限性
- 关于native T1弛豫时间、整体纵向应变和细胞外容积分数与死亡结局的分析,数据有限,无法进行确定性分析。
- 使用native T1弛豫时间、细胞外容积分数和整体纵向应变进行风险分层需进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Accurate risk stratification of nonischemic dilated cardiomyopathy (NIDCM) remains challenging. OBJECTIVE: To evaluate the association of cardiac magnetic resonance (CMR) imaging-derived measurements with clinical outcomes in NIDCM. DATA SOURCES: MEDLINE, Embase, Cochrane Library, and Web of Science Core Collection databases were systematically searched for articles from January 2005 to April 2023. STUDY SELECTION: Prospective and retrospective nonrandomized diagnostic studies reporting on the association between CMR imaging-derived measurements and adverse clinical outcomes in NIDCM were deemed eligible. DATA EXTRACTION AND SYNTHESIS: Prespecified items related to patient population, CMR imaging measurements, and clinical outcomes were extracted at the study level by 2 independent reviewers. Random-effects models were fitted using restricted maximum likelihood estimation and the method of Hartung, Knapp, Sidik, and Jonkman. MAIN OUTCOMES AND MEASURES: All-cause mortality, cardiovascular mortality, arrhythmic events, heart failure events, and major adverse cardiac events (MACE). RESULTS: A total of 103 studies including 29 687 patients with NIDCM were analyzed. Late gadolinium enhancement (LGE) presence and extent (per 1%) were associated with higher all-cause mortality (hazard ratio [HR], 1.81 [95% CI, 1.60-2.04]; P < .001 and HR, 1.07 [95% CI, 1.02-1.12]; P = .02, respectively), cardiovascular mortality (HR, 2.43 [95% CI, 2.13-2.78]; P < .001 and HR, 1.15 [95% CI, 1.07-1.24]; P = .01), arrhythmic events (HR, 2.69 [95% CI, 2.20-3.30]; P < .001 and HR, 1.07 [95% CI, 1.03-1.12]; P = .004) and heart failure events (HR, 1.98 [95% CI, 1.73-2.27]; P < .001 and HR, 1.06 [95% CI, 1.01-1.10]; P = .02). Left ventricular ejection fraction (LVEF) (per 1%) was not associated with all-cause mortality (HR, 0.99 [95% CI, 0.97-1.02]; P = .47), cardiovascular mortality (HR, 0.97 [95% CI, 0.94-1.00]; P = .05), or arrhythmic outcomes (HR, 0.99 [95% CI, 0.97-1.01]; P = .34). Lower risks for heart failure events (HR, 0.97 [95% CI, 0.95-0.98]; P = .002) and MACE (HR, 0.98 [95% CI, 0.96-0.99]; P < .001) were observed with higher LVEF. Higher native T1 relaxation times (per 10 ms) were associated with arrhythmic events (HR, 1.07 [95% CI, 1.01-1.14]; P = .04) and MACE (HR, 1.06 [95% CI, 1.01-1.11]; P = .03). Global longitudinal strain (GLS) (per 1%) was not associated with heart failure events (HR, 1.06 [95% CI, 0.95-1.18]; P = .15) or MACE (HR, 1.03 [95% CI, 0.94-1.14]; P = .43). Limited data precluded definitive analysis for native T1 relaxation times, GLS, and extracellular volume fraction (ECV) with respect to mortality outcomes. CONCLUSION: The presence and extent of LGE were associated with various adverse clinical outcomes, whereas LVEF was not significantly associated with mortality and arrhythmic end points in NIDCM. Risk stratification using native T1 relaxation times, extracellular volume fraction, and global longitudinal strain requires further evaluation.
引用
- Eichhorn C, Koeckerling D, Reddy RK, et al. Risk Stratification in Nonischemic Dilated Cardiomyopathy Using CMR Imaging: A Systematic Review and Meta-Analysis. JAMA. 2024. PMID: 39298146. doi:10.1001/jama.2024.13946
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。